Furthermore, the DGE analysis performed in this study revealed that HER2 IHC 2 + /Amplified tumours are more frequently ER + , more enriched with ER signalling pathways and its associated genes like ESR1 and BCL2 and less likely to include tumours with HER2-E molecular subtype. Here, BCL2 is linked to neoplasm.